Share-based Payment Arrangement, Expense of PSYCHEMEDICS CORP from 31 Dec 2017 to 31 Dec 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
PSYCHEMEDICS CORP quarterly and annual Share-based Payment Arrangement, Expense in USD history and change rate from 31 Dec 2017 to 31 Dec 2024.
  • PSYCHEMEDICS CORP Share-based Payment Arrangement, Expense for the quarter ending 31 Dec 2024 was $117,000, a 37% decline year-over-year.
  • PSYCHEMEDICS CORP Share-based Payment Arrangement, Expense for the twelve months ending 31 Dec 2024 was $917,000, a 0.99% increase year-over-year.
  • PSYCHEMEDICS CORP annual Share-based Payment Arrangement, Expense for 2024 was $917,000, a 0.99% increase from 2023.
  • PSYCHEMEDICS CORP annual Share-based Payment Arrangement, Expense for 2023 was $908,000, a 4.1% increase from 2022.
  • PSYCHEMEDICS CORP annual Share-based Payment Arrangement, Expense for 2022 was $872,000, a 17% increase from 2021.
Source SEC data
View on sec.gov
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

PSYCHEMEDICS CORP Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q4 2024 $917,000 $117,000 -$70,000 -37% 01 Oct 2024 31 Dec 2024 10-K 24 Mar 2025 2024 FY
Q3 2024 $987,000 $228,000 -$173,000 -43% 01 Jul 2024 30 Sep 2024 10-Q 12 Nov 2024 2024 Q3
Q2 2024 $1,160,000 $275,000 +$132,000 +92% 01 Apr 2024 30 Jun 2024 10-Q 13 Aug 2024 2024 Q2
Q1 2024 $1,028,000 $297,000 +$120,000 +68% 01 Jan 2024 31 Mar 2024 10-Q 14 May 2024 2024 Q1
Q4 2023 $908,000 $187,000 +$9,000 +5.1% 01 Oct 2023 31 Dec 2023 10-K 24 Mar 2025 2024 FY
Q3 2023 $899,000 $401,000 +$124,000 +45% 01 Jul 2023 30 Sep 2023 10-Q 12 Nov 2024 2024 Q3
Q2 2023 $775,000 $143,000 -$95,000 -40% 01 Apr 2023 30 Jun 2023 10-Q 13 Aug 2024 2024 Q2
Q1 2023 $870,000 $177,000 -$2,000 -1.1% 01 Jan 2023 31 Mar 2023 10-Q 14 May 2024 2024 Q1
Q4 2022 $872,000 $178,000 -$1,000 -0.56% 01 Oct 2022 31 Dec 2022 10-K 28 Mar 2024 2023 FY
Q3 2022 $873,000 $277,000 +$99,000 +56% 01 Jul 2022 30 Sep 2022 10-Q 13 Nov 2023 2023 Q3
Q2 2022 $774,000 $238,000 +$69,000 +41% 01 Apr 2022 30 Jun 2022 10-Q 14 Aug 2023 2023 Q2
Q1 2022 $705,000 $179,000 -$38,000 -18% 01 Jan 2022 31 Mar 2022 10-Q 11 May 2023 2023 Q1
Q4 2021 $743,000 $179,000 +$65,000 +57% 01 Oct 2021 31 Dec 2021 10-K 27 Mar 2023 2022 FY
Q3 2021 $678,000 $178,000 +$52,000 +41% 01 Jul 2021 30 Sep 2021 10-Q 10 Nov 2022 2022 Q3
Q2 2021 $626,000 $169,000 +$9,000 +5.6% 01 Apr 2021 30 Jun 2021 10-Q 10 Aug 2022 2022 Q2
Q1 2021 $617,000 $217,000 +$54,000 +33% 01 Jan 2021 31 Mar 2021 10-Q 11 May 2022 2022 Q1
Q4 2020 $563,000 $114,000 -$136,000 -54% 01 Oct 2020 31 Dec 2020 10-K 27 Mar 2023 2022 FY
Q3 2020 $699,000 $126,000 -$64,000 -34% 01 Jul 2020 30 Sep 2020 10-Q 15 Nov 2021 2021 Q3
Q2 2020 $763,000 $160,000 -$1,000 -0.62% 01 Apr 2020 30 Jun 2020 10-Q 12 Aug 2021 2021 Q2
Q1 2020 $764,000 $163,000 +$5,000 +3.2% 01 Jan 2020 31 Mar 2020 10-Q 13 May 2021 2021 Q1
Q4 2019 $759,000 $250,000 01 Oct 2019 31 Dec 2019 10-K 30 Mar 2022 2021 FY
Q3 2019 $190,000 01 Jul 2019 30 Sep 2019 10-Q 10 Nov 2020 2020 Q3
Q2 2019 $161,000 01 Apr 2019 30 Jun 2019 10-Q 13 Aug 2020 2020 Q2
Q1 2019 $158,000 01 Jan 2019 31 Mar 2019 10-Q 15 May 2020 2020 Q1

PSYCHEMEDICS CORP Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $917,000 +$9,000 +0.99% 01 Jan 2024 31 Dec 2024 10-K 24 Mar 2025 2024 FY
2023 $908,000 +$36,000 +4.1% 01 Jan 2023 31 Dec 2023 10-K 24 Mar 2025 2024 FY
2022 $872,000 +$129,000 +17% 01 Jan 2022 31 Dec 2022 10-K 28 Mar 2024 2023 FY
2021 $743,000 +$180,000 +32% 01 Jan 2021 31 Dec 2021 10-K 27 Mar 2023 2022 FY
2020 $563,000 -$196,000 -26% 01 Jan 2020 31 Dec 2020 10-K 27 Mar 2023 2022 FY
2019 $759,000 +$165,000 +28% 01 Jan 2019 31 Dec 2019 10-K 30 Mar 2022 2021 FY
2018 $594,000 +$12,000 +2.1% 01 Jan 2018 31 Dec 2018 10-K 26 Mar 2021 2020 FY
2017 $582,000 01 Jan 2017 31 Dec 2017 10-K 25 Feb 2020 2019 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.